Adjunctive Lisdexamfetamine in Bipolar Depression

Trial Profile

Adjunctive Lisdexamfetamine in Bipolar Depression

Phase of Trial: Phase III

Latest Information Update: 04 Sep 2015

At a glance

  • Drugs Lisdexamfetamine (Primary)
  • Indications Bipolar disorders
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 28 Mar 2014 Status changed from recruiting to discontinued as reported by record.
    • 29 Oct 2012 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013 as reported by
    • 21 Jun 2011 Additional lead trial centre identified as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top